Pharmaceutical Continuous Manufacturing Market to Grow at a CAGR of 9.8% to reach US$ 3,064.38 Million from 2020 to 2027

Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - Covid-19 Impact and Global Analysis by Product (Integrated Systems, Semi-Continuous Systems, Controls); Application (End Product Manufacturing, API Manufacturing); End User (Full-Scale Manufacturing Companies, R&D Departments) and Geography

Publication Month: Apr 2020 | Report Code: TIPRE00008245 | No. of Pages: 239 | Category: Pharmaceuticals | Status: Published
Covid

The pharmaceutical continuous manufacturing market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027.

 

Continuous manufacturing in the pharmaceuticals industry is a result of advancements in technology with respect to the production techniques. In the past years, the traditional method of batch manufacturing was followed in the pharmaceuticals industry. However, the development in technology has accelerated mass production with improved quality, and it has addressed many primary issues such as the recall of drugs. The pharmaceuticals industry has recently begun to acknowledge the continuous manufacturing as an option to improve and sustain manufacturing operations.

 

Lucrative Regions forPharmaceutical Continuous ManufacturingMarkets

Lucrative Regions forPharmaceutical Continuous ManufacturingMarkets

Get more information on this report :


 

 

Market Insights

Increasing Shortage of Medicines

Shortages of essential medicines and drugs are becoming increasingly frequent worldwide. The rising shortage is resulting in burden on the health systems along with additional costs as well as risk to the patients’ health. The patients in need of medicines are failing to receive appropriate doses due to unavailability of medicines. According to WHO Drug Information 2016, shortages of essential medicines have been reported from low, middle, and high-income countries. Medicines shortages pose risks for patient health as a result of non-treatment, under-treatment and possible medication errors from attempts to substitute missing medicines.

The Food and Drug Administration (FDA) states that the reasons for drug shortages occur for various reasons including quality problems, manufacturing inefficiency, delays, and discontinuations. The drugs that are often short in supply include sterile injectable and oncology/cancer treatments. The notice from manufacturers to the FDA regarding the impending or current shortages of drugs allows the FDA to work with the manufacturers over finding feasible solutions, one of which is usually ramping up the manufacturing of drugs through implementation of new and advanced systems such as continuous manufacturing.

In 2018, the US FDA developed a new Drug Shortage Task Force to explore the reasons and causes of drug shortages. The Task Force analyzed 163 drugs that went short in supply from 2013 to 2017. Moreover, a survey from The Institute for Safe Medication Practices (ISMP) in 2017 revealed that the treatment category was most commonly involved in drug shortages.

The scenario of drug shortage is also prevalent in the European countries. For instance, according to a report published by The Economist Intelligence Unit Limited in 2017, the prevalence of medicine shortage was highin Europe. The three major causes determined for the shortage included manufacturing, economic and regulatory causes. Thus, to meet the rising demand for biologics and drugs and to curb the lack of drug availability, pharmaceutical continuous manufacturing market holds a promising growth scenario.

 

Product-BasedInsights

In 2019, the integrated systems segment accounted for the largest market share ofthe global pharmaceutical continuous manufacturing market. The integrated systems are expected to dominate the product segment owing to their easy availability and accessibility as well as higher adoption of these systems than the semi-continuous systems and the controls. The integrated systems help build the continuous flow during manufacturing process, facilitate end-to-end integration, and improve asset utilization.

 

Global Pharmaceutical Continuous Manufacturing Market, by Product– 2019 & 2027

Global Pharmaceutical Continuous Manufacturing Market, by Product– 2019 & 2027

Get more information on this report :


 

Application-BasedInsights

Based on application, the pharmaceutical continuous manufacturing market is segmented into end product manufacturing and API manufacturing. The end product manufacturing segment held a largershare of the market in 2019. However, the API manufacturing segment is estimated to register a higherCAGR in the market during the forecast period.Rise in the number of pharmaceutical companies, technological advancements in continuous manufacturing systems and rise in the demand for pharmaceutical drugs are key drivers forthe growth of the end product manufacturing market.

 

End User-BasedInsights

Based on end user, the pharmaceutical continuous manufacturing market is segmented into full-scale manufacturing companies and R&D departments. The full-scale manufacturing companies segment held a largershare of the market in 2019. Also, the same segment is estimated to register a higherCAGR in the market during the forecast period.This is attributed to the increasing adoption of continuous technologies to address the challenges related to product quality, drug supply, and operational costs.

 

Strategic Insights

Partnerships and acquisitions are the mostcommonly adopted strategiesby companies to expand their footprints worldwide and meet the growing demand. The market players most commonly adopt these strategies in order to expand its product portfolio.

For instance, in May 2019, Thermo Fisher Scientific has acquired a drug substance-manufacturing site in Cork, Ireland, from GlaxoSmithKline to meet customer demand for the development and commercial manufacturing of complex active pharmaceutical ingredients (APIs).

 

Global Pharmaceutical Continuous Manufacturing Market – ByProduct

  • Integrated Systems
  • Semi-Continuous Systems
    • Continuous Granulators
    • Continuous Blenders
    • Continuous Compressors
    • Continuous Coaters
    • Continuous Dryers
    • Other Semi-Continuous Systems
  • Controls


Global Pharmaceutical Continuous Manufacturing Market – By Application

  • End Product Manufacturing
    • Solid Dosage Manufacturing
    • Liquid Dosage Manufacturing
  • API Manufacturing


Global Pharmaceutical Continuous Manufacturing Market – By End User

  • Full Scale Manufacturing Companies
    • Pharmaceutical Companies
    • Contract Manufacturing Organizations
  • R&D Departments
    • Contract Research Organizations
    • Research Institutes


Pharmaceutical Continuous ManufacturingMarket– By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

  • GEA Group
  • Thermo Fisher Scientific, Inc.
  • Glatt GmbH
  • Munson Machinery Co., Inc.
  • Hosokawa Micron Group
  • Coperion GmbH
  • Gericke AG
  • Powerex Corp
  • Freund-Vector Corporation
  • Fette Compacting
  • LEISTRITZ AG
  • KORSCH AG
  • ACG
  • Cadmach Machinery Co. Pvt. Ltd.
  • ALEXANDERWERK AG
  • Hovione

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Pharmaceutical Continuous Manufacturing Market – By Product

1.3.2        Global Pharmaceutical Continuous Manufacturing Market – By Application

1.3.3        Global Pharmaceutical Continuous Manufacturing Market – By End User

1.3.4        Global Pharmaceutical Continuous Manufacturing Market – By Geography

2.             Pharmaceutical Continuous Manufacturing Market –  Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Pharmaceutical Continuous Manufacturing – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America

4.2.2        Europe

4.2.3        Asia Pacific

4.2.4        Middle East & Africa

4.2.5        South and Central America

4.3       Expert Opinion

5.             Global Pharmaceutical Continuous Manufacturing Market – Industry Dynamics

5.1       Key Drivers

5.1.1        Increasing Shortage of Medicines

5.1.2        Advantages Offered by Continuous Manufacturing Process

5.2       Key Market Restraints

5.2.1        High Capital Investments

5.3       Key Market Opportunities

5.3.1        Emerging Markets

5.4       Future Trends

5.4.1        Increasing Adoption of Continuous Manufacturing in Pharmaceuticals

5.5       Impact Analysis

6.             Pharmaceutical Continuous Manufacturing Market – Global Analysis

6.1       Global Pharmaceutical Continuous Manufacturing Market Revenue Forecast And Analysis

6.2       Global Pharmaceutical Continuous Manufacturing Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Pharmaceutical Continuous Manufacturing Market Analysis – By Product

7.1       Overview

7.2       Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)

7.3       Integrated Systems

7.3.1        Overview

7.3.2        Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

7.4       Semi-Continuous Systems

7.4.1        Overview

7.4.2        Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

7.4.3        Continuous Granulators

7.4.3.1      Overview

7.4.3.2      Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ Million)

7.4.4        Continuous Blenders

7.4.4.1      Overview

7.4.4.2      Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ Million)

7.4.5        Continuous Compressors

7.4.5.1      Overview

7.4.5.2      Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

7.4.6        Continuous Coaters

7.4.6.1      Overview

7.4.6.2      Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ Million)

7.4.7        Continuous Dryers

7.4.7.1      Overview

7.4.7.2      Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ Million)

7.4.8        Other Semi-Continuous Systems

7.4.8.1      Overview

7.4.8.2      Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

7.5       Controls

7.5.1        Overview

7.5.2        Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ Million)

8.             Pharmaceutical Continuous Manufacturing Market–  By Application

8.1       Overview

8.2       Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)

8.3       End Product Manufacturing

8.3.1        Overview

8.3.2        End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

8.3.3        Solid Dosage Manufacturing

8.3.3.1      Overview

8.3.3.2      Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

8.3.4        Liquid Dosage Manufacturing

8.3.4.1      Overview

8.3.4.2      Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

8.4       API Manufacturing

8.4.1        Overview

8.4.2        API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

9.             Pharmaceutical Continuous Manufacturing Market –  By End User

9.1       Overview

9.2       Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)

9.3       Full-Scale Manufacturing Companies

9.3.1        Overview

9.3.2        Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

9.3.3        Pharmaceutical Companies

9.3.3.1      Overview

9.3.3.2      Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

9.3.4        Contract Manufacturing Organizations

9.3.4.1      Overview

9.3.4.2      Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

9.4       R&D Departments

9.4.1        Overview

9.4.2        R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

9.4.3        Contract Research Organizations

9.4.3.1      Overview

9.4.3.2      Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

9.4.4        Research Institutes

9.4.4.1      Overview

9.4.4.2      Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ million)

10.          Pharmaceutical Continuous Manufacturing Market – Geographic Analysis

10.1.1     Overview

10.1.2     North America: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

10.1.3     North America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.1.3.1    North America: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.1.4     North America: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027  (USD Million)

10.1.4.1    North America: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.1.5     North America: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027  (USD Million)

10.1.5.1    North America: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.1.5.2    North America: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.1.6     North America: Pharmaceutical Continuous Manufacturing Market, by Country, 2019 & 2027 (%)

10.1.7     US: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    US: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    US: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.1.7.2.1    US: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.1.7.3    US: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.1.7.3.1    US: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.1.7.4    US: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.1.7.4.1    US: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.1.7.4.2    US: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.1.8     Canada: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

10.1.8.1    Canada: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Canada: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.1.8.2.1    Canada: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.1.8.3    Canada: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.1.8.3.1    Canada: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.1.8.4    Canada: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.1.8.4.1    Canada: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.1.8.4.2    Canada: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.1.9     Mexico: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

10.1.9.1    Mexico: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Mexico: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.1.9.2.1    Mexico: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.1.9.3    Mexico: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.1.9.3.1    Mexico: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.1.9.4    Mexico: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.1.9.4.1    Mexico: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.1.9.4.2    Mexico: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.2    Europe: Pharmaceutical Continuous Manufacturing Market

10.2.1     Overview

10.2.2     Europe: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027  (USD Million)

10.2.3     Europe: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.2.3.1    Europe: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.2.4     Europe: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.2.4.1    Europe: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.2.5     Europe: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.2.5.1    Europe: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.2.5.2    Europe: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.2.6     Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)

10.2.7     Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

10.2.7.1    Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2    Germany: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.2.7.2.1    Germany: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.2.7.3    Germany: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.2.7.3.1    Germany: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.2.7.4    Germany: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.2.7.4.1    Germany: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.2.7.4.2    Germany: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.2.8     UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1    UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2    UK: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.2.8.2.1    UK: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.2.8.3    UK: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.2.8.3.1    UK: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.2.8.4    UK: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.2.8.4.1    UK: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.2.8.4.2    UK: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.2.9     France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

10.2.9.1    France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2    France: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.2.9.2.1    France: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.2.9.3    France: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.2.9.3.1    France: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.2.9.4    France: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.2.9.4.1    France: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.2.9.4.2    France: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.2.10   Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Spain: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.2.10.2.1 Spain: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.2.10.3 Spain: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.2.10.3.1 Spain: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.2.10.4 Spain: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.2.10.4.1 Spain: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.2.10.4.2 Spain: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.2.11   Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1 Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2 Italy: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.2.11.2.1 Italy: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.2.11.3 Italy: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.2.11.3.1 Italy: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.2.11.4 Italy: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.2.11.4.1 Italy: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.2.11.4.2 Italy: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.3    Asia Pacific: Pharmaceutical Continuous Manufacturing Market

10.3.1     Overview

10.3.2     Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.3.2.1    Asia Pacific: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.3.3     Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027  (USD Million)

10.3.3.1    Asia Pacific: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.3.4     Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.3.4.1    Asia Pacific: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.3.4.2    Asia Pacific: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.3.5     Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)

10.3.6     China: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.3.6.1    China: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.3.6.1.1    China: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.3.6.2    China: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.3.6.2.1    China: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.3.6.3    China: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.3.6.3.1    China: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.3.6.3.2    China: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.3.7     Japan: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.1    Japan: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.3.7.1.1    Japan: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.3.7.2    Japan: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.3.7.2.1    Japan: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.3.7.3    Japan: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.3.7.3.1    Japan: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.3.7.3.2    Japan: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.3.8     India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1    India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.2    India: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.3.8.2.1    India: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.3.8.3    India: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.3.8.3.1    India: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.3.8.4    India: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.3.8.4.1    India: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.3.8.4.2    India: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.3.9     South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

10.3.9.1    South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.2    South Korea: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.3.9.2.1    South Korea: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.3.9.3    South Korea: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.3.9.3.1    South Korea: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.3.9.4    South Korea: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.3.9.4.1    South Korea: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.3.9.4.2    South Korea: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.3.10   Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

10.3.10.1 Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 Australia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.3.10.2.1 Australia: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.3.10.3 Australia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.3.10.3.1 Australia: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.3.10.4 Australia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.3.10.4.1 Australia: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.3.10.4.2 Australia: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.4    Middle East & Africa: Pharmaceutical Continuous Manufacturing Market

10.4.1     Overview

10.4.2     Middle East & Africa: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (USD Million)

10.4.3     Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027  (USD Million)

10.4.3.1    Middle East & Africa: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.4.4     Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.4.4.1    Middle East & Africa: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.4.5     Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027  (USD Million)

10.4.5.1    Middle East & Africa: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.4.5.2    Middle East & Africa: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.4.6     Middle East & Africa: Pharmaceutical Continuous Manufacturing Market Share by Country –  2019 & 2027, (%)

10.4.7     Saudi Arabia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.1    Saudi Arabia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.2    Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.4.7.2.1    Saudi Arabia: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.4.7.3    Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.4.7.3.1    Saudi Arabia: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.4.7.4    Saudi Arabia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.4.7.4.1    Saudi Arabia: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.4.7.4.2    Saudi Arabia: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.4.8     UAE: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.1    UAE: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.2    UAE: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.4.8.2.1    UAE: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.4.8.3    UAE: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.4.8.3.1    UAE: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.4.8.4    UAE: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.4.8.4.1    UAE: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.4.8.4.2    UAE: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.4.9     South Africa: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (US$ Million)

10.4.9.1    South Africa: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.2    South Africa: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.4.9.2.1    South Africa: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.4.9.3    South Africa: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.4.9.3.1    South Africa: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.4.9.4    South Africa: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.4.9.4.1    South Africa: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.4.9.4.2    South Africa: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.5    South and Central America: Pharmaceutical Continuous Manufacturing Market

10.5.1     Overview

10.5.2     South and Central America: Pharmaceutical Continuous Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)

10.5.3     South and Central America: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.5.3.1    South and Central America: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.5.4     South and Central America: Pharmaceutical Continuous Manufacturing Market, by Application,  2018–2027 (USD Million)

10.5.4.1    South and Central America: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.5.5     South and Central America: Pharmaceutical Continuous Manufacturing Market, by End User,  2018–2027 (USD Million)

10.5.5.1    South and Central America: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.5.5.2    South and Central America: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.5.6     South and Central America: Pharmaceutical Continuous Manufacturing Market, by Country,  2018 & 2027 (%)

10.5.7     Brazil: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1    Brazil: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.2    Brazil: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.5.7.2.1    Brazil: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.5.7.3    Brazil: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.5.7.3.1    Brazil: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.5.7.4    Brazil: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.5.7.4.1    Brazil: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.5.7.4.2    Brazil: R&D Departments Market, by Type, 2018–2027 (USD Million)

10.5.8     Argentina: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

10.5.8.1    Argentina: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.2    Argentina: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)

10.5.8.2.1    Argentina: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)

10.5.8.3    Argentina: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)

10.5.8.3.1    Argentina: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)

10.5.8.4    Argentina: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)

10.5.8.4.1    Argentina: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)

10.5.8.4.2    Argentina: R&D Departments Market, by Type, 2018–2027 (USD Million)

11.          Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

11.2    Europe: Impact Assessment of COVID-19 Pandemic

11.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4    Rest of World: Impact Assessment of COVID-19 Pandemic

12.          Pharmaceutical Continuous Manufacturing Market –Industry Landscape

12.1    Overview

12.2    Growth Strategies

12.2.1     Overview

13.          Company Profiles

13.1    GEA Group

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    Coperion GmbH

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Gericke AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Glatt GmbH

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Hosokawa Micron Group

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Munson Machinery Co., Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Powrex Corp

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    THERMO FISHER SCIENTIFIC INC.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    ACG

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Cadmach Machinery Co. Pvt. Ltd.

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

13.11 Fette Compacting

13.11.1   Key Facts

13.11.2   Business Description

13.11.3   Products and Services

13.11.4   Financial Overview

13.11.5   SWOT Analysis

13.11.6   Key Developments

13.12 Freund-Vector Corporation

13.12.1   Key Facts

13.12.2   Business Description

13.12.3   Products and Services

13.12.4   Financial Overview

13.12.5   SWOT Analysis

13.12.6   Key Developments

13.13 KORSCH AG

13.13.1   Key Facts

13.13.2   Business Description

13.13.3   Products and Services

13.13.4   Financial Overview

13.13.5   SWOT Analysis

13.13.6   Key Developments

13.14 LEISTRITZ AG

13.14.1   Key Facts

13.14.2   Business Description

13.14.3   Products and Services

13.14.4   Financial Overview

13.14.5   SWOT Analysis

13.14.6   Key Developments

13.15 ALEXANDERWERK AG

13.15.1   Key Facts

13.15.2   Business Description

13.15.3   Products and Services

13.15.4   Financial Overview

13.15.5   SWOT Analysis

13.15.6   Key Developments

13.16 Hovione

13.16.1   Key Facts

13.16.2   Business Description

13.16.3   Products and Services

13.16.4   Financial Overview

13.16.5   SWOT Analysis

13.16.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             North America Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 2.             North America Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 3.             North America Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             North America Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 7.             North America R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             US Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 9.             US Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 10.          US Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 11.          US End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          US Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 13.          US Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          US R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 16.          Canada: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 17.          Canada: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 18.          Canada: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          Canada: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 20.          Canada: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 21.          Canada: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 22.          Mexico: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 23.          Mexico: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 24.          Mexico: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 25.          Mexico: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 26.          Mexico: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 27.          Mexico: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 28.          Mexico: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 29.          Europe Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 30.          Europe: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 31.          Europe: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 32.          Europe: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 33.          Europe: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 34.          Europe: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 35.          Europe: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 36.          Germany: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 37.          Germany: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 38.          Germany: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 39.          Germany: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 40.          Germany: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 41.          Germany: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 42.          Germany: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 43.          UK: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 44.          UK: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 45.          UK: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 46.          UK: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 47.          UK: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 48.          UK: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 49.          UK: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 50.          France: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 51.          France: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 52.          France: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 53.          France: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 54.          France: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 55.          France: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 56.          France: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 57.          Spain: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 58.          Spain: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 59.          Spain: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 60.          Spain: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 61.          Spain: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 62.          Spain: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 63.          Spain: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 64.          Italy: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 65.          Italy: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 66.          Italy: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 67.          Italy: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 68.          Italy: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 69.          Italy: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 70.          Italy: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 71.          Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 72.          Asia Pacific: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 73.          Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 74.          Asia Pacific: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 75.          Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 76.          Asia Pacific: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 77.          Asia Pacific: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 78.          China: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 79.          China: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 80.          China: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 81.          China: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 82.          China: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 83.          China: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 84.          China: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 85.          Japan: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 86.          Japan: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 87.          Japan: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 88.          Japan: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 89.          Japan: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 90.          Japan: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 91.          Japan: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 92.          India: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 93.          India: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 94.          India: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 95.          India: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 96.          India: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 97.          India: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 98.          India: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 99.          South Korea: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 100.       South Korea: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 101.       South Korea: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 102.       South Korea: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 103.       South Korea: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 104.       South Korea: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 105.       South Korea: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 106.       Australia: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 107.       Australia: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 108.       Australia: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 109.       Australia: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 110.       Australia: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 111.       Australia: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 112.       Australia: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 113.       Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 114.       Middle East & Africa: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027  (USD Million)

Table 115.       Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 116.       Middle East & Africa: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 117.       Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 118.       Middle East & Africa: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 119.       Middle East & Africa: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 120.       Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 121.       Saudi Arabia Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 122.       Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 123.       Saudi Arabia End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 124.       Saudi Arabia Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 125.       Saudi Arabia Full-Scale Manufacturing Companies Market, by Type– Revenue and Forecast to 2027  (USD Million)

Table 126.       Saudi Arabia R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 127.       UAE: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 128.       UAE: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 129.       UAE: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 130.       UAE: End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 131.       UAE: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 132.       UAE: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 133.       UAE: R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 134.       South Africa: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 135.       South Africa: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 136.       South Africa: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 137.       South Africa: End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 138.       South Africa: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 139.       South Africa: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 140.       South Africa: R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 141.       South and Central America: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 142.       South and Central America: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027  (USD Million)

Table 143.       South and Central America: Pharmaceutical Continuous Manufacturing Market, by Application –  Revenue and Forecast to 2027 (USD Million)

Table 144.       South and Central America: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 145.       South and Central America: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 146.       South and Central America: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 147.       South and Central America: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 148.       Brazil: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 149.       Brazil: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 150.       Brazil: Pharmaceutical Continuous Manufacturing Market, by Application– Revenue and Forecast to 2027  (USD Million)

Table 151.       Brazil: End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 152.       Brazil: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 153.       Brazil: Full-Scale Manufacturing Companies Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 154.       Brazil: R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 155.       Argentina: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 156.       Argentina: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 157.       Argentina: Pharmaceutical Continuous Manufacturing Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 158.       Argentina: End Product Manufacturing Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 159.       Argentina: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 160.       Argentina: Full-Scale Manufacturing Companies Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 161.       Argentina: R&D Departments Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 162.       Recent Growth Strategies In The Pharmaceutical Continuous Manufacturing Market

Table 163.       Glossary of Terms, Pharmaceutical Continuous Manufacturing Market

 

LIST OF FIGURES

Figure 1.           Pharmaceutical Continuous Manufacturing Market Segmentation

Figure 2.           Pharmaceutical Continuous Manufacturing Segmentation, By Region

Figure 3.           Global Pharmaceutical Continuous Manufacturing Market Overview

Figure 4.           The Integrated Systems Segment Held Largest Share Of Product Segment In Pharmaceutical Continuous Manufacturing Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Pharmaceutical Continuous Manufacturing Market, By Geography (US$ Million)

Figure 7.           Global Pharmaceutical Continuous Manufacturing Market- Leading Country Markets (US$ Million)

Figure 8.           North America PEST Analysis

Figure 9.           Europe: PEST Analysis

Figure 10.        Asia Pacific PEST Analysis

Figure 11.        Middle East & Africa PEST Analysis

Figure 12.        South and Central America PEST Analysis

Figure 13.        Global Pharmaceutical Continuous Manufacturing Market – Revenue Forecast And Analysis – 2019- 2027

Figure 14.        Global Pharmaceutical Continuous Manufacturing Market – By Geography Forecast And Analysis – 2019- 2027

Figure 15.        Market Positioning Of Key Players In Global Pharmaceutical Continuous Manufacturing Market

Figure 16.        Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)

Figure 17.        Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ Million)

Figure 18.        Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 ( US$ Million)

Figure 21.        Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ Million)

Figure 23.        Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ Million)

Figure 24.        Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Pharmaceutical Continuous Manufacturing Market Share, by application, 2019 and 2027 (%)

Figure 27.        End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

Figure 28.        Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

Figure 29.        Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

Figure 30.        API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ million)

Figure 31.        Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)

Figure 32.        Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

Figure 33.        Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

Figure 34.        Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

Figure 35.        R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ million)

Figure 36.        Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)

Figure 37.        Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027  (US$ million)

Figure 38.        North America: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019)  (USD Million)

Figure 39.        North America Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 40.        North America: Pharmaceutical Continuous Manufacturing Market, by Country, 2019 & 2027 (%)

Figure 41.        US: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        Canada: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 43.        Mexico: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 44.        Europe: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 45.        Europe Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 46.        Europe: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)

Figure 47.        Germany: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 48.        UK: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        France: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        Spain: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 51.        Italy: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 52.        Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019)  (USD Million)

Figure 53.        Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 54.        China: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        Japan: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 56.        India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 58.        Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 59.        Middle East & Africa: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 60.        Middle East & Africa Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027  (USD Million)

Figure 61.        Middle East & Africa: Pharmaceutical Continuous Manufacturing Market Share by Country – 2019 & 2027, (%)

Figure 62.        Saudi Arabia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027  (USD Million)

Figure 63.        UAE: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        South Africa: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 65.        South and Central America: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)

Figure 66.        South and Central America Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)

Figure 67.        South and Central America: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)

Figure 68.        Brazil: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 69.        Argentina: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)

Figure 70.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 71.        Impact of COVID-19 Pandemic in Europe Country Markets

Figure 72.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Figure 73.        Impact of COVID-19 Pandemic in Rest of World Country Markets

 

The List of Companies - Pharmaceutical Continuous Manufacturing Market

  1. GEA Group
  2. Coperion GmbH
  3. Gericke AG
  4. Glatt GmbH
  5. Hosokawa Micron Group
  6. Munson Machinery Co. Inc.
  7. Powrex Corp
  8. Thermo Fisher Scientific Inc.
  9. Freund-vector Corporation
  10. Fette Compacting
  11. Alexanderwerk
  12. LEISTRITZ AG
  13. KORSCH AG
  14. ACG
  15. Cadmach Machinery Co. Pvt. Ltd.
  16. Hovioneen Aesica

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmaceutical continuous manufacturing market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global pharmaceutical continuous manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00008245
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Continuous Manufacturing technology is a method in which continuous development of products is involved to allow faster manufacturing with more productive and profitable products. The continuous manufacturing method in the pharmaceutical attributes to the production of an active component in a compressed unit with a high degree of automation. The market is driven by less time investment, less production cost, faster availability of reliable products in the market.

The growth of the market is attributed to some key driving factors such as increasing shortage of medicines, and advantages offered by continuous manufacturing process. However, high capital costs required for the establishment of these systems expected to restraint the growth of the market during the forecast years.

Global pharmaceutical continuous manufacturing market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for pharmaceutical continuous manufacturing. The federal government in the US and regulatory authorities are supportive towards transition from batch to continuous manufacturing of drugs and APIs which is leading to increasing number of companies and contract manufacturers adopting the techniques thereby leading to the market growth.The Asia Pacific region is expected to account for the fastest growth in the pharmaceutical continuous manufacturing market. In Japan and South Korea, the market is expected to grow owing to factors such as the large population countries such as China and India, increasing focus of market players towards Asian countries to open new production facilities in these regions, rising number of pharmaceutical companies.

Pricing